Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jürg Nussberger
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Living Beings
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
145
Brunner, Hans
109
Waeber, Bernard
42
Burnier, Michel
28
Aubert, Jean-François
18
Maillard, Marc
10
Waeber, Gérard
10
Cugno, Massimo
9
Mazzolai, Lucia
8
Agostoni, Angelo
8
Biollaz, Jérôme
8
Hayoz, Daniel
5
Cicardi, Marco
5
Zanchi, Anne
4
Chiolero, Arnaud
4
Pedrazzini, Thierry
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jürg Nussberger (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Pellegrin Maxime; Alonso Florian; Aubert Jean-François; Bouzourene Karima; Braunersreuther Vincent; Mach François; Haefliger Jacques-Antoine; Hayoz Daniel; Berthelot Alain; Nussberger Jürg; Laurant Pascal; Mazzolai Lucia
Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes.
Hypertension 2009;53(5):782-9.
-
2008: Nussberger Jürg; Aubert Jean-François; Bouzourene Karima; Pellegrin Maxime; Hayoz Daniel; Mazzolai Lucia
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Hypertension 2008;51(5):1306-11.
-
2008: Flammer Andreas J; Sudano Isabella; Hermann Frank; Gay Steffen; Forster Adrian; Neidhart Michel; Künzler Peter; Enseleit Frank; Périat Daniel; Hermann Matthias; Nussberger Juerg; Luscher Thomas F; Corti Roberto; Noll Georg; Ruschitzka Frank
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
Circulation 2008;117(17):2262-9.
-
2008: Danser A H Jan; Charney Alan; Feldman David L; Nussberger Juerg; Fisher Naomi; Hollenberg Norman
The renin rise with aliskiren: it's simply stoichiometry.
Hypertension 2008;51(4):e27-8; author reply e29.
-
2008: Tissot Alain C; Maurer Patrik; Nussberger Juerg; Sabat Robert; Pfister Thomas; Ignatenko Stanislav; Volk Hans-Dieter; Stocker Hans; Müller Philipp; Jennings Gary T; Wagner Frank; Bachmann Martin F
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
Lancet 2008;371(9615):821-7.
-
2007: Jonkam Collette C; Enkhbaatar Perenlei; Nakano Yoshimitsu; Boehm Thomas; Wang Jianpu; Nussberger Juerg; Esechie Aimalohi; Traber Lillian D; Herndon David; Traber Daniel L
Effects of the bradykinin B2 receptor antagonist icatibant on microvascular permeability after thermal injury in sheep.
Shock (Augusta, Ga.) 2007;28(6):704-9.
-
2007: Garruti Gabriella; Giusti Vittorio; Nussberger Jürg; Darimont Christian; Verdumo Chantal; Amstutz Catherine; Puglisi Francesco; Giorgino Francesco; Giorgino Riccardo; Cotecchia Susanna
Expression and secretion of the atrial natriuretic peptide in human adipose tissue and preadipocytes.
Obesity (Silver Spring, Md.) 2007;15(9):2181-9.
-
2007: Nussberger J; Gradman A H; Schmieder R E; Lins R L; Chiang Y; Prescott M F
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
International journal of clinical practice 2007;61(9):1461-8.
-
2007: Bork Konrad; Frank Jorge; Grundt Boris; Schlattmann Peter; Nussberger Juerg; Kreuz Wolfhart
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
The Journal of allergy and clinical immunology 2007;119(6):1497-503.
-
2007: Eap Chin B; Bochud Murielle; Elston Robert C; Bovet Pascal; Maillard Marc P; Nussberger Juerg; Schild Laurent; Shamlaye Conrad; Burnier Michel
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Hypertension 2007;49(5):1007-14.
-
2007: Nussberger J
[Blood pressure lowering tripeptides derived from milk protein]
Therapeutische Umschau. Revue thérapeutique 2007;64(3):177-9.
-
2007: O'Brien Eoin; Barton John; Nussberger Juerg; Mulcahy David; Jensen Chris; Dicker Patrick; Stanton Alice
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
Hypertension 2007;49(2):276-84.
-
2007: Ambühl Patrice M; Tissot Alain C; Fulurija Alma; Maurer Patrik; Nussberger Juerg; Sabat Robert; Nief Vera; Schellekens Charlotte; Sladko Katja; Roubicek Kirsten; Pfister Thomas; Rettenbacher Manfred; Volk Hans-Dieter; Wagner Frank; Müller Philipp; Jennings Gary T; Bachmann Martin F
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Journal of hypertension 2007;25(1):63-72.
-
2006: Zanchi Anne; Perregaux Christine; Maillard Marc; Cefai Daniel; Nussberger Juerg; Burnier Michel
The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
American journal of physiology. Endocrinology and metabolism 2006;291(6):E1228-34.
-
2006: Bochud Murielle; Nussberger Jürg; Bovet Pascal; Maillard Marc R; Elston Robert C; Paccaud Fred; Shamlaye Conrad; Burnier Michel
Plasma aldosterone is independently associated with the metabolic syndrome.
Hypertension 2006;48(2):239-45.
-
2006: Mazzolai Lucia; Korber Martine; Bouzourene Karima; Aubert Jean-François; Nussberger Jürg; Stamenkovic Ivan; Hayoz Daniel
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Atherosclerosis 2006;186(1):86-91.
-
2006: Bachmann Martin F; Nussberger Jürg; Tissot Alain C; Jennings Gary T
Reply to 'Blood pressure vaccine shot down by safety concerns'.
Nature medicine 2006;12(3):270.
-
2006: Azizi Michel; Webb Randy; Nussberger Juerg; Hollenberg Norman K
Renin inhibition with aliskiren: where are we now, and where are we going?
Journal of hypertension 2006;24(2):243-56.
-
2005: Hasler Christopher; Nussberger Jürg; Maillard Marc; Forclaz Andrei; Brunner Hans R; Burnier Michel
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 2005;78(5):501-7.
-
2005: Wuerzner Grégoire; Chiolero Arnaud; Maillard Marc; Nussberger Jürg; Burnier Michel
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.
Kidney international 2005;68(2):688-94.
-
2005: Gröger Moritz; Lebesgue Diane; Pruneau Didier; Relton Jane; Kim Seong-Woong; Nussberger Jürg; Plesnila Nikolaus
Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2005;25(8):978-89.
-
2005: Cugno Massimo; Agostoni Piergiuseppe; Mari Daniela; Meroni Pier Luigi; Gregorini Luisa; Bussotti Maurizio; Anguissola Gian Battista; Donatelli Francesco; Nussberger Jürg
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
British journal of haematology 2005;130(1):113-20.
-
2005: Fiebeler Anette; Nussberger Jürg; Shagdarsuren Erdenechimeg; Rong Song; Hilfenhaus Georg; Al-Saadi Nidal; Dechend Ralf; Wellner Maren; Meiners Silke; Maser-Gluth Christiane; Jeng Arco Y; Webb Randy L; Luft Friedrich C; Muller Dominik N
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Circulation 2005;111(23):3087-94.
-
2005: Gradman Alan H; Schmieder Roland E; Lins Robert L; Nussberger Juerg; Chiang Yanntong; Bedigian Martin P
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
Circulation 2005;111(8):1012-8.
-
2004: Brakch Noureddine; Abdel-Sayed Saad; Allemandou Flore; Wang Qing; Aubert Jean F; Brunner Hans R; Nussberger Juerg
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Journal of hypertension 2004;22(9):1797-803.
-
2004: Mazzolai Lucia; Duchosal Michel A; Korber Martine; Bouzourene Karima; Aubert Jean François; Hao Hiroyuki; Vallet Veronique; Brunner Hans-R; Nussberger Jürg; Gabbiani Giulio; Hayoz Daniel
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Hypertension 2004;44(3):277-82.
-
2004: Zanchi Anne; Chiolero Arnaud; Maillard Marc; Nussberger Jürg; Brunner Hans-Rudolf; Burnier Michel
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
The Journal of clinical endocrinology and metabolism 2004;89(3):1140-5.
-
2004: Ferrari Paolo; Shaw Sidney G; Nicod Jérôme; Saner Esther; Nussberger Jürg
Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Journal of hypertension 2004;22(2):377-81.
-
2004: Wuerzner Grégoire; Chioléro Arnaud; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel;
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Kidney international 2004;65(1):238-44.
-
2004: Nussberger Jürg; Koike Hiroyuki
Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.
Clinical therapeutics 2004;26 Suppl A():A12-20.
-
2003: Abdel-Sayed Saad; Brunner Hans Rudolf; Nussberger Juerg
Volume expansion enhances plasma endothelin-1.
American journal of hypertension 2003;16(12):1057-61.
-
2003: Stanton Alice; Jensen Chris; Nussberger Juerg; O'Brien Eoin
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.
Hypertension 2003;42(6):1137-43.
-
2003: Brakch Noureddine; Nussberger Juerg
Blood pressure regulation in low renin subjects.
Journal of hypertension 2003;21(10):1821-2.
-
2003: Abdel-Sayed Saad; Nussberger Juerg; Aubert Jean François; Gohlke Peter; Brunner Hans Rudolf; Brakch Noureddine
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects.
American journal of hypertension 2003;16(7):515-21.
-
2003: Nussberger Jürg
Investigating mineralocorticoid hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S25-30.
-
2003: Cugno Massimo; Nussberger Jürg; Cicardi Marco; Agostoni Angelo
Bradykinin and the pathophysiology of angioedema.
International immunopharmacology 2003;3(3):311-7.
-
2003: Forclaz Andrei; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension 2003;41(1):31-6.
-
2002: Regamey Frédéric; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Hypertension 2002;40(3):266-72.
-
2002: Nussberger Juerg; Cugno Massimo; Cicardi Marco
Bradykinin-mediated angioedema.
The New England journal of medicine 2002;347(8):621-2.
-
2002: Wang Qing; Hummler Edith; Nussberger Jürg; Clément Sophie; Gabbiani Giulio; Brunner Hans R; Burnier Michel
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Journal of the American Society of Nephrology : JASN 2002;13(6):1509-16.
-
2002: Maillard Marc P; Würzner Grégoire; Nussberger Jürg; Centeno Catherine; Burnier Michel; Brunner Hans R
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Clinical pharmacology and therapeutics 2002;71(1):68-76.
-
2002: Nussberger Juerg; Wuerzner Grégoire; Jensen Chris; Brunner Hans R
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Hypertension 2002;39(1):E1-8.
-
2001: Pellieux C; Foletti A; Peduto G; Aubert J F; Nussberger J; Beermann F; Brunner H R; Pedrazzini T
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
The Journal of clinical investigation 2001;108(12):1843-51.
-
2001: Cugno M; Nussberger J; Biglioli P; Alamanni F; Coppola R; Agostoni A
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.
Chest 2001;120(6):1776-82.
-
2001: Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
Bradykinin in the ascitic fluid of patients with liver cirrhosis.
Clinical science (London, England : 1979) 2001;101(6):651-7.
-
2001: Würzner G; Chiolero A; Maillard M; Nussberger J; Hayoz D; Brunner H R; Burnier M
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Kidney international 2001;60(4):1469-76.
-
2001: Brunner H R; Nussberger J
Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(1):S15-20.
-
2001: Wang Q; Hummler E; Maillard M; Nussberger J; Rossier B C; Brunner H R; Burnier M
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Kidney international 2001;59(6):2216-21.
-
2001: Nussberger J; Brunner D B; Nyfeler J A; Linder L; Brunner H R
Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood.
Clinical chemistry 2001;47(4):726-9.
-
2000: Burnier M; Monod M L; Chioléro A; Maillard M; Nussberger J; Brunner H R
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Journal of hypertension 2000;18(11):1657-64.
-
2000: Cugno M; Agostoni P; Brunner H R; Gardinali M; Agostoni A; Nussberger J
Plasma bradykinin levels in human chronic congestive heart failure.
Clinical science (London, England : 1979) 2000;99(5):461-6.
-
2000: Chiolero A; Maillard M; Nussberger J; Brunner H R; Burnier M
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Hypertension 2000;36(4):631-7.
-
2000: Mazzolai L; Pedrazzini T; Nicoud F; Gabbiani G; Brunner H R; Nussberger J
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Hypertension 2000;35(4):985-91.
-
2000: Maillard M P; Rossat J; Nussberger J; Ramis J; Pontes C; Burnier M; Brunner H R
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Journal of cardiovascular pharmacology 2000;35(3):383-9.
-
2000: Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner H R; Biollaz J
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
European journal of clinical pharmacology 2000;55(10):749-54.
-
1999: Maillard M P; Mazzolai L; Daven V; Centeno C; Nussberger J; Brunner H R; Burnier M
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
American journal of hypertension 1999;12(12 Pt 1-2):1201-8.
-
1999: Nussberger J; Cugno M; Cicardi M; Agostoni A
Local bradykinin generation in hereditary angioedema.
The Journal of allergy and clinical immunology 1999;104(6):1321-2.
-
1999: Burnier M; Fricker A F; Hayoz D; Nussberger J; Brunner H R
Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects.
European journal of clinical pharmacology 1999;55(9):633-7.
-
1999: Agostoni A; Cicardi M; Cugno M; Zingale L C; Gioffré D; Nussberger J
Angioedema due to angiotensin-converting enzyme inhibitors.
Immunopharmacology 1999;44(1-2):21-5.
-
1999: Cugno M; Nussberger J; Biglioli P; Giovagnoni M G; Gardinali M; Agostoni A
Cardiopulmonary bypass increases plasma bradykinin concentrations.
Immunopharmacology 1999;43(2-3):145-7.
-
1999: Rossat J; Maillard M; Nussberger J; Brunner H R; Burnier M
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Clinical pharmacology and therapeutics 1999;66(1):76-84.
-
1999: Rousso P; Buclin T; Nussberger J; Décosterd L A; La Roche S D; Brunner-Ferber F; Brunner H R; Biollaz J
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Journal of hypertension 1999;17(3):427-37.
-
1999: Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner H R; Burnier M
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Hypertension 1999;33(3):850-5.
-
1999: Pechère-Bertschi A; Nussberger J; Burnier M
[Does constitutional hypotension exist?]
Therapeutische Umschau. Revue thérapeutique 1999;56(1):49-54.
-
1998: Fricker A F; Nussberger J; Meilenbrock S; Brunner H R; Burnier M
Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
Kidney international 1998;54(6):2089-97.
-
1998: Pechère-Bertschi A; Nussberger J; Biollaz J; Fahti M; Grouzmann E; Morgan T; Brunner H R; Burnier M
Circadian variations of renal sodium handling in patients with orthostatic hypotension.
Kidney international 1998;54(4):1276-82.
-
1998: Nussberger J; Cugno M; Amstutz C; Cicardi M; Pellacani A; Agostoni A
Plasma bradykinin in angio-oedema.
Lancet 1998;351(9117):1693-7.
-
1998: Mazzolai L; Nussberger J; Aubert J F; Brunner D B; Gabbiani G; Brunner H R; Pedrazzini T
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Hypertension 1998;31(6):1324-30.
-
1998: Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner H R; Burnier M
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Journal of hypertension 1998;16(3):385-93.
-
1998: Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner H R; Biollaz J
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
Journal of cardiovascular pharmacology 1998;31(3):408-17.
-
1997: Hagmann M; Nussberger J; Naudin R B; Burns T S; Karim A; Waeber B; Brunner H R
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
Journal of cardiovascular pharmacology 1997;29(4):444-50.
-
1997: Wiesel P; Mazzolai L; Nussberger J; Pedrazzini T
Two-kidney, one clip and one-kidney, one clip hypertension in mice.
Hypertension 1997;29(4):1025-30.
-
1996: Noël B; Del Re G; Capone P; Brunner H R; Nussberger J
Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081.
Journal of cardiovascular pharmacology 1996;28(2):252-8.
-
1996: Evéquoz D; Aubert J F; Nussberger J; Biollaz J; Diezi J; Brunner H R; Waeber B
Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.
Nephron 1996;73(3):467-72.
-
1995: Haefliger J A; Bergonzelli G; Waeber G; Aubert J F; Nussberger J; Gavras H; Nicod P; Waeber B
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats.
Hypertension 1995;26(5):733-7.
-
1995: Evéquoz D; Grouzmann E; Nussberger J; Niederberger M; Brunner H R; Waeber B
Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats.
Regulatory peptides 1995;58(3):163-6.
-
1995: Delacrétaz E; Zanchi A; Nussberger J; Hayoz D; Aubert J F; Brunner H R; Waeber B
Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Hypertension 1995;26(2):332-6.
-
1995: Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner H R
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):108-15.
-
1995: Favrat B; Burnier M; Nussberger J; Lecomte J M; Brouard R; Waeber B; Brunner H R
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Journal of hypertension 1995;13(7):797-804.
-
1995: Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner H R
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Journal of cardiovascular pharmacology 1995;25(6):986-93.
-
1995: Zanchi A; Schaad N C; Osterheld M C; Grouzmann E; Nussberger J; Brunner H R; Waeber B
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
The American journal of physiology 1995;268(6 Pt 2):H2267-73.
-
1995: Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner H R
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Hypertension 1995;25(4 Pt 1):602-9.
-
1995: Niederberger M; Aubert J F; Nussberger J; Brunner H R; Waeber B
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Journal of hypertension 1995;13(4):439-45.
-
1995: Delacrétaz E; Nussberger J; Biollaz J; Waeber B; Brunner H R
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
Hypertension 1995;25(1):14-21.
-
1994: Brunner H R; Nussberger J; Waeber B
Dose-response relationships of ACE inhibitors and angiotensin II blockers.
European heart journal 1994;15 Suppl D():123-8.
-
1994: Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss H P; Brunner H R
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
European heart journal 1994;15 Suppl D():113-22.
-
1994: Brunner H R; Delacrétaz E; Nussberger J; Burnier M; Waeber B
Angiotensin II antagonists DuP 753 and TCV 116.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(9):S29-34.
-
1994: Pellacani A; Brunner H R; Nussberger J
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Clinical science (London, England : 1979) 1994;87(5):567-74.
-
1994: Delacrétaz E; Nussberger J; Püchler K; Wood A J; Robinson P R; Waeber B; Brunner H R
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
Journal of cardiovascular pharmacology 1994;24(3):479-85.
-
1994: Zanchi A; Nussberger J; Criscuoli M; Capone P; Brunner H R
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
Journal of cardiovascular pharmacology 1994;24(2):317-22.
-
1994: Zusman R M; Hui K Y; Nussberger J; Christensen D M; Higgins J; Carlson W D; Schoenfeld D; Haber E
R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers.
American journal of hypertension 1994;7(4 Pt 1):295-301.
-
1994: Evequoz D; Burnier M; Niederberger M; Brunner H R; Nussberger J; Waeber B
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Clinical and experimental pharmacology & physiology 1994;21(2):93-100.
-
1993: Brunner H R; Nussberger J; Waeber B
Control of vascular tone by renin and angiotensin in cardiovascular disease.
European heart journal 1993;14 Suppl I():149-53.
-
1993: Brunner H R; Nussberger J; Burnier M; Waeber B
Angiotensin II antagonists.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(6):1221-38.
-
1993: Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner H R
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Hypertension 1993;22(3):339-47.
-
1993: Porchet M; Nussberger J; Brunner H R; Waeber B
[Blood pressure recording in outpatient service: experience with the Sandoz Pressure System]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(11):320-2.
-
1993: Brunner H R; Nussberger J; Waeber B
Angiotensin antagonists.
Advances in nephrology from the Necker Hospital 1993;22():305-27.
-
1993: Hayoz D; Nussberger J; Waeber B; Brunner H R
The renin-angiotensin system and arterial wall behavior.
Journal of cardiovascular pharmacology 1993;22 Suppl 5():S48-52.
-
1992: Brunner H R; Waeber B; Nussberger J
Strategies for the management of hypertension in aircrew.
European heart journal 1992;13 Suppl H():45-9.
-
1992: Brunner H R; Christen Y; Munafo A; Lee R J; Waeber B; Nussberger J
Clinical experience with angiotensin II receptor antagonists.
American journal of hypertension 1992;5(12 Pt 2):243S-246S.
-
1992: Hayoz D; Rutschmann B; Perret F; Niederberger M; Tardy Y; Mooser V; Nussberger J; Waeber B; Brunner H R
Conduit artery compliance and distensibility are not necessarily reduced in hypertension.
Hypertension 1992;20(1):1-6.
-
1992: Nussberger J; Brunner D; Keller I; Brunner H R
Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
American journal of hypertension 1992;5(6 Pt 1):393-8.
-
1992: Munafo A; Christen Y; Nussberger J; Shum L Y; Borland R M; Lee R J; Waeber B; Biollaz J; Brunner H R
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Clinical pharmacology and therapeutics 1992;51(5):513-21.
-
1992: Ganslmayer M; Perret F; Waeber B; Nussberger J; Brunner H R
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder]
Schweizerische medizinische Wochenschrift 1992;122(15):544-8.
-
1992: Aubert J F; Walker P; Grouzmann E; Nussberger J; Brunner H R; Waeber B
Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats.
Clinical and experimental pharmacology & physiology 1992;19(4):223-8.
-
1992: Pellacani A; Brunner H R; Nussberger J
Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S28-34.
-
1991: Niederberger M; Hayoz D; Rutschmann B; Tardy Y; Nussberger J; Waeber B; Brunner H R
Neither hydralazine nor captopril significantly shifts carotid artery distensibility-pressure curves determined in intact spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S404-5.
-
1991: Nussberger J; Flückiger J P; Hui K Y; Evéquoz D; Waeber B; Brunner H R
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S230-1.
-
1991: Waeber B; Niederberger M; Nussberger J; Brunner H R
Ambulatory blood pressure monitoring in children, adolescents and elderly people.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(8):S72-4.
-
1991: Perret F; Mooser V; Hayoz D; Tardy Y; Meister J J; Etienne J D; Farine P A; Marazzi A; Burnier M; Nussberger J
Evaluation of arterial compliance-pressure curves. Effect of antihypertensive drugs.
Hypertension 1991;18(4 Suppl):II77-83.
-
1991: Camenzind E; Nussberger J; Juillerat L; Munafo A; Fischli W; Coassolo P; van Brummelen P; Kleinbloesem C H; Waeber B; Brunner H R
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Journal of cardiovascular pharmacology 1991;18(3):299-307.
-
1991: Burnier M; Ganslmayer M; Perret F; Porchet M; Kosoglou T; Gould A; Nussberger J; Waeber B; Brunner H R
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):181-91.
-
1991: Evéquoz D; Reichenstein T; Waeber B; Nussberger J; Brunner H R
[ACE inhibitors in the treatment of hypertension in elderly patients]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1991;80(25):701-6.
-
1991: Christen Y; Waeber B; Nussberger J; Porchet M; Borland R M; Lee R J; Maggon K; Shum L; Timmermans P B; Brunner H R
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
Circulation 1991;83(4):1333-42.
-
1991: Christen Y; Waeber B; Nussberger J; Lee R J; Timmermans P B; Brunner H R
Dose-response relationships following oral administration of DuP 753 to normal humans.
American journal of hypertension 1991;4(4 Pt 2):350S-353S.
-
1991: Scherrer U; Nussberger J; Torriani S; Waeber B; Darioli R; Hofstetter J R; Brunner H R
Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium.
Circulation 1991;83(2):552-8.
-
1990: Vonmoos S; Nussberger J; Waeber B; Biollaz J; Brunner H R; Leuenberger P
Effect of metoclopramide on angiotensins, aldosterone, and atrial peptide during hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;69(6):2072-7.
-
1990: Brunner H R; Nussberger J; Waeber B
Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S149-53.
-
1990: Christen Y; Ganslmayer M; Waeber B; Burnier M; Nussberger J; Brunner H R
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(6):S119-24.
-
1990: Juillerat L; Nussberger J; Ménard J; Mooser V; Christen Y; Waeber B; Graf P; Brunner H R
Determinants of angiotensin II generation during converting enzyme inhibition.
Hypertension 1990;16(5):564-72.
-
1990: Waeber B; Burnier M; Nussberger J; Brunner H R
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S37-41.
-
1990: Christen Y; Waeber B; Nussberger J; Brunner H R
Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in man.
Journal of clinical pharmacology 1990;30(8):711-4.
-
1990: Nussberger J; Mooser V; Maridor G; Juillerat L; Waeber B; Brunner H R
Caffeine-induced diuresis and atrial natriuretic peptides.
Journal of cardiovascular pharmacology 1990;15(5):685-91.
-
1990: Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner H R
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Journal of cardiovascular pharmacology 1990;15(2):276-82.
-
1990: Waeber B; Nussberger J; Brunner H R
[Angiotensin-converting-enzyme inhibition in arterial hypertension]
Wiener medizinische Wochenschrift (1946) 1990;140(1-2):22-30.
-
1990: Waeber B; Evéquoz D; Aubert J F; Flückiger J P; Juillerat L; Nussberger J; Brunner H R
Prevention of renal hypertension in the rat by neuropeptide Y.
Journal of hypertension 1990;8(1):21-5.
-
1990: Lattion A L; Flückiger J P; Waeber B; Nussberger J; Aubert J F; Brunner H R
Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.
Experientia 1990;46(1):69-72.
-
1990: Waeber B; Nussberger J; Grouzmann E; Burnier M; Brunner H R
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):667-72.
-
1990: Flückiger J P; Deghenghi R; Waeber B; Immer H U; Nussberger J; Brunner H R
Effects of dextronatrin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats.
Fundamental & clinical pharmacology 1990;4(2):129-39.
-
1990: Waeber B; Niederberger M; Gavras H; Nussberger J; Brunner H R
Hemodynamic effects of a kinin antagonist.
Journal of cardiovascular pharmacology 1990;15 Suppl 6():S78-82.
-
1989: Burnier M; Waeber B; Nussberger J; Brunner H R
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S27-31.
-
1989: Perret F; Mooser V; Waeber B; Yanik T; Jean-Jacques M; Mooser E; Nussberger J; Brunner H R
Effect of cold pressor test on the internal diameter of the radial artery.
American journal of hypertension 1989;2(9):727-8.
-
1989: Flückiger J P; Gremaud G; Waeber B; Kulik A; Ichino A; Nussberger J; Brunner H R
Measurement of sympathetic nerve activity in the unanesthetized rat.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;67(1):250-5.
-
1989: Nussberger J; Delabays A; De Gasparo M; Cumin F; Waeber B; Brunner H R; Ménard J
Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Hypertension 1989;13(6 Pt 2):948-53.
-
1989: Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert H D; Luther R; Brunner H R
Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Hypertension 1989;13(6 Pt 2):941-7.
-
1989: Waeber B; Burnier M; Perret F; Nussberger J; Brunner H R
Ambulatory blood pressure measurement and antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S33-9.
-
1989: de Gasparo M; Cumin F; Nussberger J; Guyenne T T; Wood J M; Menard J
Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
British journal of clinical pharmacology 1989;27(5):587-96.
-
1989: Waeber B; Nussberger J; Perret L; Santoni J P; Brunner H R
Experience with perindopril in normal volunteers.
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 1():35-41.
-
1989: Burnier M; Mooser V; Wauters J P; Marder H K; De Vane P; Nussberger J; Waeber B; Brunner H R
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Journal of cardiovascular pharmacology 1989;13(5):682-90.
-
1989: Nussberger J; Waeber B; Brunner H R
Angiotensin converting enzyme inhibition and renin inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(2):S75-9.
-
1989: Nussberger J; Waeber B; Brunner H R
Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
American journal of hypertension 1989;2(4):286-93.
-
1989: Mooser V; Burnier M; Nussberger J; Juillerat L; Waeber B; Brunner H R
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Journal of hypertension 1989;7(3):211-6.
-
1989: Nussberger J; Juillerat L; Perret F; Waeber B; Bellet M; Brunner J; Ménard J
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
American heart journal 1989;117(3):717-22.
-
1989: Delabays A; Porchet M; Waeber B; Nussberger J; Brunner H R
Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers.
Journal of cardiovascular pharmacology 1989;13(1):173-6.
-
1989: Burnier M; Waeber B; Nussberger J; Brunner H R
Pharmacokinetics of angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;28 Suppl 2():133S-139S; discussion 140S.
-
1989: Nussberger J; Waeber B; Brunner H R
Clinical pharmacology of ACE inhibition.
Cardiology 1989;76 Suppl 2():11-22.
-
1989: Waeber B; Juillerat-Jeanneret L; Aubert J F; Schapira M; Nussberger J; Brunner H R
Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;27 Suppl 2():175S-180S.
-
1989: Waeber B; Nussberger J; Perret L; Santoni J P; Brunner H R
Experience with perindopril in normal volunteers.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11 Suppl 2():507-19.
-
1989: Erard P Y; Gardaz J P; Nussberger J; Livio J J; Waeber B; Brunner H R; Freeman J
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R198.
-
1989: Waeber G; Burnier M; Porchet M; Nussberger J; Waeber B; Brunner H R
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
European journal of clinical pharmacology 1989;36(6):587-91.
-
1989: Burnier M; Mooser V; Nussberger J; Waeber B; Brunner H R
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
British journal of clinical pharmacology 1989;27 Suppl 2():189S-197S.
-
1989: Waeber B; Nussberger J; Juillerat L; Brunner H R
Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S53-9.
-
1988: Nussberger J; Keller I; Waeber B; Brunner H R
Angiotensin II measurement with high-affinity monoclonal antibodies.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S424-5.
-
1988: Mooser V; Waeber B; Nussberger J; Brunner H R
Antihypertensive effect of diltiazem administered once and twice daily.
Journal of human hypertension 1988;2(4):257-60.
-
1988: Brunner H R; Waeber B; Nussberger J
What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(3):S1-5.
-
1988: Mimran A; Nussberger J; Ribstein J; Waeber B; Brunner H R
Response of atrial natriuretic peptide to acute saline loading in essential hypertension.
The American journal of physiology 1988;255(6 Pt 2):F1085-90.
-
1988: Waeber G; Schapira M; Waeber B; Aubert J F; Nussberger J; Brunner H R
Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
Circulatory shock 1988;26(4):375-82.
-
1988: Torriani S; Waeber B; Petrillo A; Di Stefano R; Mooser V; Scherrer U; Nussberger J; Hofstetter J R; Brunner H R
Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(1):S25-7.
-
1988: Waeber B; Aubert J F; Flückiger J P; Nussberger J; Vavrek R J; Stewart J M; Brunner H R
Role of endogenous bradykinin in blood pressure control of conscious rats.
Kidney international. Supplement 1988;26():S63-8.
-
1988: Brunner H R; Waeber B; Nussberger J
Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
Kidney international. Supplement 1988;26():S80-5.
-
1988: Aubert J F; Waeber B; Rossier B; Geering K; Nussberger J; Brunner H R
Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
The Journal of pharmacology and experimental therapeutics 1988;246(3):1088-92.
-
1988: Petrillo A; Scherrer U; Gonvers J J; Nussberger J; Marder H; de Vane P; Waeber B; Hofstetter J R; Brunner H R
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Journal of cardiovascular pharmacology 1988;12(3):279-85.
-
1988: Lattion A L; Aubert J F; Flückiger J P; Nussberger J; Waeber B; Brunner H R
Effect of sodium intake on gene expression and plasma levels of ANF in rats.
The American journal of physiology 1988;255(2 Pt 2):H245-9.
-
1988: Corder R; Waeber B; Evequoz D; Nussberger J; Gaillard R; Brunner H
Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats.
Journal of cardiovascular pharmacology 1988;12(2):140-3.
-
1988: Waeber B; Aubert J F; Corder R; Evéquoz D; Nussberger J; Gaillard R; Brunner H R
Cardiovascular effects of neuropeptide Y.
American journal of hypertension 1988;1(2):193-9.
-
1988: Waeber G; Beck G; Waeber B; Bidiville J; Nussberger J; Brunner H R
Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Journal of hypertension 1988;6(3):239-45.
-
1988: Burnier M; Waeber B; Aubert J F; Nussberger J; Brunner H R
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
The American journal of physiology 1988;254(3 Pt 2):H509-16.
-
1988: Aubert J F; Burnier M; Waeber B; Nussberger J; Dipette D J; Burris J F; Brunner H R
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
The Journal of pharmacology and experimental therapeutics 1988;244(3):1109-15.
-
1988: Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner H R
Individual responses to converting enzyme inhibitors and calcium antagonists.
Hypertension 1988;11(2):166-73.
-
1988: Evéquoz D; Waeber B; Aubert J F; Flückiger J P; Nussberger J; Brunner H R
Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy.
Circulation research 1988;62(1):25-30.
-
1988: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist.
Journal of cardiovascular pharmacology 1988;11(1):51-5.
-
1988: Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner H R
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Fundamental & clinical pharmacology 1988;2(5):413-29.
-
1988: Nussberger J; Brunner D B; Waeber B; Brunner H R
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Life sciences 1988;42(17):1683-8.
-
1988: Burgener E; Mooser V; Waeber B; Porchet M; Gardaz J P; Nussberger J; Brunner H R
Calcium entry blockade attenuates the acute blood pressure rise induced by cigarette smoking.
Journal of cardiovascular pharmacology 1988;12 Suppl 6():S126-30.
-
1988: Goy J J; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner H R
Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Journal of cardiovascular pharmacology 1988;12(5):562-70.
-
1988: Flückiger J P; Waeber B; Mimran A; Nussberger J; Wahba W K; Brunner H R
Enhanced urinary kallikrein excretion in response to a moderate sodium load in genetically hypertensive rats.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S36-42.
-
1987: Evéquoz D; Waeber B; Corder R; Nussberger J; Gaillard R; Brunner H R
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y.
Life sciences 1987;41(23):2573-80.
-
1987: Evéquoz D; Waeber B; Matsueda G; Nussberger J; Brunner H R
Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy.
European journal of pharmacology 1987;144(2):217-21.
-
1987: Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner H R
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Journal of clinical hypertension 1987;3(4):510-3.
-
1987: Aubert J F; Burnier M; Waeber B; Nussberger J; Brunner H R
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):681-5.
-
1987: Schaller M D; Nussberger J; Feihl F; Waeber B; Brunner H R; Perret C; Nicod P
Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction.
The American journal of cardiology 1987;60(14):1178-80.
-
1987: Biollaz J; Bidiville J; Diézi J; Waeber B; Nussberger J; Brunner-Ferber F; Gomez H J; Brunner H R
Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
Kidney international 1987;32(4):537-46.
-
1987: Waeber B; Corder R; Aubert J F; Nussberger J; Gaillard R; Brunner H R
Influence of sodium intake on circulating levels of neuropeptide Y.
Life sciences 1987;41(11):1391-6.
-
1987: Waeber B; Scherrer U; Petrillo A; Bidiville J; Nussberger J; Waeber G; Hofstetter J R; Brunner H R
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording.
Lancet 1987;2(8561):732-4.
-
1987: Waeber B; Aubert J F; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakes.
Clinical and experimental pharmacology & physiology 1987;14(8):659-64.
-
1987: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
[Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin]
Archives des maladies du coeur et des vaisseaux 1987;80(6):832-4.
-
1987: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
Agents and actions. Supplements 1987;22():349-54.
-
1987: Brunner H R; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Nephron 1987;47 Suppl 1():87-9.
-
1987: Nussberger J; de Gasparo M; Juillerat L; Guyenne T T; Mooser V; Waeber B; Brunner H R
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1353-66.
-
1987: Brunner H R; Nussberger J; Bidiville J; Waeber G; Porchet M; Waeber B
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.
Journal of cardiovascular pharmacology 1987;10 Suppl 10():S87-9.
-
1987: Kaufmann U; Schapira M; Waeber B; Nussberger J; Brunner H R
Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
Circulatory shock 1987;23(3):215-23.
Sign-in to see more
